cGxP.wire https://validator.w3.org/feed/docs/rss2.html HUTCHMED Reports Phase III Lung Cancer Trial Success Summit Therapeutics and Akeso Report Ivonescimab Survival Benefit GT Medical Technologies Expands GammaTile Center Program Allergan Aesthetics Reveals Global Layered Beauty Report Alkeus Reports Positive Gildeuretinol Results in Stargardt Disease Milestone Pharmaceuticals Secures First Overseas Etripamil Approval Pendopharm and Ascendis Pharma Gain Canada Reimbursement Recommendation for Yorvipath PixCell Medical Expands HemoScreen Access Across Canada Evotec and Plectonic Advance T-Cell Engagers for Solid Tumors Stoke Therapeutics and Biogen Report 4-Year Data Supporting Zorevunersen’s Potential in Dravet Syndrome SkinMedica Launches New Barrier Calming Cream for Skin Health Tangram Therapeutics Advances TGM-312 Into MASH Patient Cohorts Devonian Health Advances Thykamine Manufacturing Quality ONWARD Medical Begins EIGER Study With First ARC-IM Implant Medtronic and Cornerstone Robotics Expand Robotic Surgery BillionToOne Launches Northstar Origin Liquid Biopsy Test Sensorion Gets France Trial Approval for SENS-601 Gene Therapy Dyne Therapeutics Advances Four DMD Exon-Skipping Candidates C4 Therapeutics to Present Cemsidomide Biomarker Data in Multiple Myeloma CytoSorbents Advances DrugSorb-ATR FDA Regulatory Path Norroy Bioscience Starts Phase III Trial of 177Lu-NYM032 Climb Bio Phase 1 Data Support CLYM116 Q12W Dosing in IgA Nephropathy Alteogen and Novartis Sign $3.2B Subcutaneous Drug Deal Nxera Pharma to Receive $8.6M Milestone Payment from Centessa for OX2R Development Aurora Cannabis Urges Rejection of Curaleaf Hostile Bid TScan Therapeutics Reorganizes to Focus on In Vivo TCR-T Cell Therapy for Solid Tumors SciSparc Pursues FDA Orphan Drug Designation for SCI-110 in Tourette Syndrome HCW Biologics Strengthens HCW9302 Patent for Alopecia Areata NovaGo Raises $30M to Advance Spinal Cord Therapy Cizzle Bio Study Supports CIZ1B for Early Lung Cancer Kazia Raises Up to $120 Million to Advance Paxalisib FibroBiologics Secures U.S. Patent for Disc Regeneration Medibyt Wins FDA Clearance for CPETWise Analysis Platform CorTec Brain Interchange Gains Second FDA Breakthrough Designation Inventiva Completes Phase 3 NATiV3 Trial of Lanifibranor in MASH AIM ImmunoTech Expands Ampligen Patent Protection in Europe and U.K. Through 2041 Revolution Medicines Reports NEJM Data for RASONQUE in NSCLC Styx and ZoeNCure Advance Next-Generation ADCs to Clinic Roche Licenses Simcere’s Tri-Specific Antibody SIM0660 Treeline Partners With Roche to Evaluate TLN-121 in Lymphoma Kazia Expands Paxalisib Trial Into HR+ Breast Cancer Pyrotech Advances PTT-121 Into Phase 1 Clinical Trial uniQure Submits BLA for AMT-130 in Huntington’s Disease Andelyn Scales AAV Manufacturing for Diabetes Gene Therapy United Therapeutics FDA Accepts Tyvaso sNDA for IPF Keenova Launches Mixed Reality Tool for Hand Health NewBiologix Partners With Synastra on DMD Gene Therapy Manufacturing Kazia Paxalisib Shows Potential in Resistant Colorectal Cancer SELLAS Presents SLS009 Preclinical Data in Pancreatic Cancer at AACR 2026 BridgeBio to Present New Infigratinib Data in Achondroplasia